Several of the scientific results obtained during these years at pre-clinical, experimental research level have been transferred in the clinics allowing the availability and development, in addition to the conventional treatments (mainly based on chemotherapy ), of new and innovative bio- and imunotherapeutic options for cancer treatments.
Since its inception the NIBIT decided to promote and increase at the national level the development of new and more effective strategies of bio- immunotherapy of malignant tumors. In more details the aims of NIBIT are as follows:
a) a) to promote and develop the scientific and professional interactions among different research professionals from Academy, Industry, Regulatory bodies dealing with the bio- immunotherapy of cancer;
b) b) to develop innovative clinical projects based on bio- immunotherapy of cancer;
c) c) to develop interactions with patients and/or relatives in order to circulate any useful information on the disease and of new trials that may be useful for patients.
Over the years different Italian groups have become members of the NIBIT thus increasing their scientific interaction, cooperation that resulted in a high number of pre-clinical and clinical projects in the area of biotherapy of cancer. Within such context the NIBIT has thus organized annual scientific meetings in Siena. To better manage all these activities a NIBIT Foundation was then created in the year 2006.
At the moment the NIBIT has a board that includes a President, a Secretary/Treasurer and 7 members. The members Assembly includes representatives of the major Italian institutions interested in the bio- immunotherapy of tumors. NIBIT also includes working groups each dealing with a specific issue and representing the University, Scientific Institutes, Oncological Hospitals and regulatory agencies.